Comprehensive long‐term safety of adalimumab from 18 clinical trials in adult patients with moderate‐to‐severe plaque psoriasis
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Dermatology"
DOI: 10.1111/bjd.17084
Abstract: Adalimumab (Humira®, AbbVie Inc., North Chicago, IL, U.S.A.) is a fully human monoclonal antibody specific for tumour necrosis factor‐α that is approved to treat adults with moderate‐to‐severe chronic plaque psoriasis. read more here.
Keywords: long term; comprehensive long; plaque psoriasis; moderate severe ... See more keywords
Comprehensive and long-term surveys of COVID-19 sequelae in Japan, an ambidirectional multicentre cohort study: study protocol
Sign Up to like & getrecommendations! Published in 2021 at "BMJ Open Respiratory Research"
DOI: 10.1136/bmjresp-2021-001015
Abstract: Introduction The rapid spread of COVID-19 posed a global burden. Substantial number of people died of the disease in the acute phase of infection. In addition, a significant proportion of patients have been reported to… read more here.
Keywords: term surveys; long term; study; comprehensive long ... See more keywords